by Elena Iemma | Feb 8, 2022 | News
PROVIDENCE, RI, February 8, 2022 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) announces the establishment of the Vax Gives Back Fund at the Rhode Island Foundation, a step to continue the strong tradition of corporate responsibility and community service at the...
by Elena Iemma | Nov 30, 2021 | News
PROVIDENCE, RI, November 30, 2021 /PRNewswire/ — Today EpiVax, Inc. (“EpiVax”) confirmed that the company’s EPV-CoV-19 vaccine epitope sequences are 98.2% conserved in the new Omicron SARS-CoV-2 variant. EpiVax and EpiVax Therapeutics, Inc....
by Elena Iemma | Nov 17, 2021 | News
PROVIDENCE, RI, November 2021 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) announces the publication of three papers focusing on malaria vaccine efficacy, part of a collaboration with Leidos, the University of Georgia Center for Vaccines and Immunology, the University...
by Elena Iemma | Nov 4, 2021 | News
PROVIDENCE, RI, November 4, 2021 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) is pleased to announce an important commercial licensing agreement with Maruho Co., Ltd. (“Maruho”) for EpiVax’s patented Tregitope technology. This marks an exciting step for Maruho and...
by Elena Iemma | Nov 4, 2021 | Events
Updated: Thank you to those that joined us for the seminar! It was a successful meeting with many wonderful talks. Please find photos from the event below. Hilton Apollolaan. Apollolaan 138, 1077 BG, Amsterdam, Netherlands Check out our previous Amsterdam...
